Related Experiment Videos
Evaluation and management of acute ischemic stroke
Birgitte H Bendixen1, Lenore Ocava
1Albert Einstein College of Medicine, Department of Neurology, 1300 Morris Park Avenue, Bronx, NY 10461-1926, USA. bbendixen@email.msn.com
Current Cardiology Reports
|February 6, 2002
Summary
Acute stroke treatments remain limited, with only two effective drugs available. Understanding stroke causes and preventing complications significantly improves patient outcomes.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Stroke is a leading cause of adult death and disability worldwide.
- Current acute stroke treatments are limited, despite extensive research investment.
- Existing therapies offer modest improvements in patient outcomes.
Purpose of the Study:
- To review the current landscape of acute stroke treatments.
- To highlight the efficacy of available therapeutic options.
- To emphasize the importance of understanding stroke pathogenesis and complication prevention.
Main Methods:
- Literature review of clinical trials and research on stroke treatments.
- Analysis of the effectiveness of recombinant tissue-plasminogen activator.
- Evaluation of danaparoid sodium for specific stroke types.
Main Results:
- Recombinant tissue-plasminogen activator increases excellent outcomes by 30%.
- Danaparoid sodium shows benefit in stroke due to large artery atherosclerosis.
- Improved understanding of stroke pathogenesis and complication management enhances outcomes.
Conclusions:
- Effective acute stroke treatments are scarce.
- Targeted therapies offer specific benefits for certain stroke types.
- Advances in understanding and prevention are crucial for improving stroke patient outcomes.